Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02555527 · ClinicalTrials.gov registry record
Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 500,000
- Enrollment target
NCT02555527: Completed study, sponsored by Duke University.
NCT02555527 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 500,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02555527 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 500,000 participants
- Enrollment target
Study Summary
To perform a cost-effectiveness analysis for the routine use of contrast in rest echocardiography in patients with dilated or ischemic cardiomyopathy from the United States healthcare system, provider and payer perspectives.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500,000 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-02 |
What the finished NCT02555527 record still lists
NCT02555527 is an observational study that tracks outcomes without assigning an intervention. Its 500,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02555527 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02555527 about?
NCT02555527 is a clinical study titled "Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment". To perform a cost-effectiveness analysis for the routine use of contrast in rest echocardiography in patients with dilated or ischemic cardiomyopathy from the United States healthcare system, provider and payer perspectives.
What is the current status of trial NCT02555527?
This trial is currently completed. The enrollment target is 500,000 participants. The study started on 2015-09. Estimated completion is 2017-02.
Who is sponsoring clinical trial NCT02555527?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05065060 · 500,000 participants
Parkinson Progression Marker Initiative Online (PPMI Online)
- NCT06017687 · 500,000 participants · NA
Data Collection and Evaluation of OptiBP Under Investigational Use
- NCT06342375 · 425,000 participants · NA
Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage
- NCT06934239 · 400,000 participants · Phase 4
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia